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Abstract
Background: Evidences that oxidative stress plays a role in the associations between outdoor air pollution and
asthma are growing. We aimed to study the role of plasma fluorescent oxidation products levels (FlOPs; an
oxidative stress-related biomarker), as potential mediators, in the associations between outdoor air pollution and
persistent asthma.
Methods: Analyses were conducted in 204 adult asthmatics followed up in the French case-control and family
study on asthma (EGEA; the Epidemiological study of the Genetic and Environmental factors of Asthma). Persistent
asthma was defined as having current asthma at EGEA2 (baseline, 2003–2007) and EGEA3 (follow-up, 2011–2013).
Exposures to nitrogen dioxide, nitrogen oxides, road traffic, particulate matter with a diameter ≤ 10 μm (PM10)
and ≤ 2.5 μm were estimated by ESCAPE models (2009–2010), and ozone (O3) by IFEN models (2004). We used a
mediation analysis to assess the mediated effect by FlOPs levels and the interaction between FlOPs levels and air
pollution.
Results: FlOPs levels increased with PM10 and O3 (adjusted β = 0.04 (95%CI 0.001–0.08), aβ = 0.04 (95%CI 0.009–0.07)
per 10 μg/m3, respectively), and the risk of persistent asthma increased with FlOPs levels (aOR = 1.81 (95%CI 1.08–
3.02)). The risk of persistent asthma decreased with exposures to NO2, NOx and PM2.5 (aOR ranging from 0.62 to
0.94), and increased with exposures to PM10, O3, O3-summer and road traffic, the greater effect being observed for O3
(aOR = 1.78, 95% CI 0.73–4.37, per 10 μg/m3). Using mediation analysis, we observed a positive total effect (aOR =
2.16, 95%CI 0.70–11.9), a positive direct effect of O3 on persistent asthma (OR = 1.68, 95%CI 0.57–7.25), and a
positive indirect effect mediated by FIOPs levels (aOR = 1.28 (95%CI 1.01–2.29)) accounting for 41% of the total
effect.
Conclusions: Our results add insights on the role of oxidative stress in the association between air pollution and
persistent asthma.
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Mediation analysis
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Background
Evidences that outdoor air pollution is associated with
asthma incidence, and various asthma phenotypes as
asthma control or asthma severity among asthmatics keep
going up [1, 2], but the associations between outdoor air
pollution and persistent asthma are very scarcely studied
in adults. To our knowledge, only one study has investi-
gated the associations between nitrogen dioxide (NO2) ex-
posure, traffic road and persistent asthma, and showed
that living close to a major road was associated with per-
sistent asthma in adults followed up over eight years [3].
The underlying biological mechanisms by which outdoor
air pollution may affect respiratory health include inflam-
matory processes, immune response modulations, genetic
modifications and oxidative stress damages, which are in-
creasingly suggested. Asthma is an oxidative stress-related
disease [4], and exposures to ozone (O3), NO2 and particu-
late matter (PM) have been found associated with oxidative
stress [5]. Studying biomarkers is a useful approach to pro-
vide new insights into the biological mechanisms that drive
the disease process, to predict the development and pro-
gression of a disease and to personalize intervention strat-
egies [6, 7]. Among the various biological markers related
to oxidative stress, plasma fluorescent oxidation products
(FlOPs) levels are biomarkers of damages that reflect sys-
temic oxidative stress [8] and are of growing interest in epi-
demiology. In prospective studies, high plasma FlOPs
levels were positively associated with the incidence of cor-
onary heart diseases (CHD) among men without previous
cardiovascular events [9], and with the risk of future CHD
in women [10]. Regarding asthma, among adults from the
Epidemiological study of the Genetic and Environmental
factors of Asthma (EGEA), we recently reported higher
plasma FlOPs levels significantly associated with asthma at-
tacks, poor asthma control and poor lung function [11].
Overall, better understanding the underlying biological
mechanisms related to asthma, and discovering novel bio-
markers is the first step towards improving asthma man-
agement. To our knowledge, only two studies have
investigated the associations between environmental fac-
tors and FlOPs levels. Among a population of U.S. trucking
industry employees, short-term exposure to occupational
PM2.5 was unrelated to plasma FlOPs levels [12]. In the
EGEA study, occupational exposure to irritant cleaning
products and to low molecular weight agents, especially
highly reactive chemicals, were significantly and positively
associated with higher plasma FlOPs levels in men, and an
association was suggested for irritant cleaning products in
women [13]. To date, the role of plasma FlOPs levels in
the association between outdoor air pollution and asthma
has never been studied.
We hypothesized that oxidative stress is one of the
underlying biological mechanisms involved in the associ-
ation between outdoor air pollution and persistent
asthma. Among adults followed up in the EGEA study, we
first studied the associations between outdoor air pollu-
tion (NO2, nitrogen oxides (NOx), particulate matter
(PM), traffic load, traffic intensity, O3 and O3-summer),
plasma FlOPs levels and persistent asthma. Then, accord-
ing to the results, we investigated the role of plasma FlOPs
levels as potential mediators in the association between
outdoor air pollution and persistent asthma. We per-
formed a mediation analysis which quantified both the
mediated effect by FlOPs levels and the interaction be-
tween FlOPs levels and outdoor air pollution.
Methods
Study design
The EGEA is a cohort study based on an initial group of
asthma cases recruited in chest clinics from five French
cities (1991–1995) along with their first-degree relatives,
and a group of controls (https://egeanet.vjf.inserm.fr/).
The protocol and descriptive characteristics have been
described previously [14, 15], and inclusion criteria used
to define asthmatic cases and controls were described in
Additional file 1. A 12-year follow-up of the initial co-
hort was conducted between 2003 and 2007 (EGEA2)
[16], and 1571 adults aged ≥16 years had a complete
examination. As a follow-up study of EGEA2, the third
survey (EGEA3, 2011–2013, n = 1558) was conducted
using self-completed questionnaire only. The EGEA col-
lection was certified ISO 9001 since 2006 to 2018 [17].
Ethical approval was obtained from the relevant institu-
tional review board committees (Cochin Port-Royal Hos-
pital and Necker-Enfants Malades Hospital, Paris). All
participants signed a written informed consent.
The analyses included 204 adults with current asthma at
EGEA2, followed up at EGEA3, and with data on outdoor
air pollution and plasma FlOPs levels (Additional file 2:
Figure S1). In comparison to participants not included in
the analyses, participants included had lower body mass
index, lived longer at the same residential address and had
lower exposure to NO2, PM2.5, O3 and O3-summer (all P-
value≤0. 05, Additional file 1: Table S1). No differences
were found regarding other variables.
Definition of persistent asthma
At EGEA2, the participants with ever asthma answered
positively to at least one of the two following questions:
“Have you ever had attacks of breathlessness at rest with
wheezing?” or “Have you ever had asthma attacks?”, or
were recruited as asthmatic cases at EGEA1. Among
participants with ever asthma, those with current asthma
reported asthma attacks or the use of asthma medication
in the past twelve months. Participants with persistent
asthma had current asthma at both EGEA2 and EGEA3,
and those with remittent asthma had current asthma
only at EGEA2. Participants with remittent asthma were
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used as reference (see Additional file 1 and for further
respiratory outcomes definitions).
Exposure assessment
Available air pollution data from ESCAPE (European
Study of Cohorts for Air Pollution Effects) were NO2,
NOx and particulate matter with a diameter ≤ 10 and ≤
2.5 μm (PM10 and PM2.5), and those from IFEN (French
Institute for the Environment) were O3 and O3-summer.
Outdoor air pollution exposures were assigned to each
participant’s residential address.
Annual air pollution levels of NO2 and particulate
matter were derived from ESCAPE standardised models
(www.escapeproject.eu). Briefly, the ESCAPE monitoring
campaigns took place between 2009 and 2010, including
40 measurement sites for NO2 and NOx in Paris, Lyon,
Grenoble and Marseille, and 20 particulate matter meas-
urement sites in Paris and Grenoble. Land-use regres-
sion (LUR) models were developed and two indicators of
road traffic exposure were also calculated. Traffic inten-
sity on nearest road was defined as the number of motor
vehicles circulating per day on the nearest road to the
participant’s home and was expressed in vehicles per
day. Total traffic load was defined as the traffic load on
all major roads based around a buffer of 100 m from the
participant’s home and was expressed by traffic intensity
multiplied by road length. Back-extrapolation was used
to transfer the current LUR models (2009–2010) to earl-
ier years (2003–2007, EGEA2) (see Additional file 1 for
more details). In our study, the estimation of outdoor air
pollution by ESCAPE took place after EGEA2, and ac-
cordingly we also analysed the back-extrapolated pollu-
tion estimates in order to obtain a better temporality
between outdoor air pollution and plasma collection.
Back-extrapolated pollution data were available for NO2
and NOx in all cities, and for PM10 in Paris. The spatial
resolution was 50m × 50m. In order to supplement the
ESCAPE data set, we used O3 and O3-summer exposures
from the IFEN (see Additional file 1 for more details).
The O3 estimate was the yearly mean ozone level in
2004 for each participant at the residential address and
derived from a geo-statistical model as described previ-
ously [18]. The O3-summer exposure was assessed from
the monthly means from April to September. The spatial
resolution was 4 km × 4 km.
Measurement of plasma FlOPs levels
Plasma samples were collected in EGEA2 between 2003 and
2006 and stored immediately at − 80 °C during 5.0 to 8.0
years until FlOPs measurements. Plasma FlOPs levels were
measured as previously described [8, 13] (Additional file 1).
Briefly, plasma was extracted into a mixture of ethanol/
ether (3/1 v/v) and measured using a spectrofluorime-
ter (360 nm excitation wavelength, 430 nm emission
wavelength). Fluorescence was expressed as a unit of
relative fluorescence intensity (RFU/mL) of plasma.
Statistical methods
Due to their skewed distribution, plasma FlOPs levels were
log10-transformed. Due to the familial dependence of the
data, multivariate analyses (except mediation analyses) took
into account dependence between observations. Linear re-
gression models and logistic regression models with ran-
dom effects on center and familial dependence were used
to study the associations between outdoor air pollution
with plasma FlOPs levels, and between outdoor air pollu-
tion and persistent asthma, respectively. To control a
potential effect of short-term exposure to O3 in the associ-
ations between O3 with plasma FlOPs levels and persistent
asthma, further adjustment for the season of plasma collec-
tion (EGEA2) was conducted. Logistic regression models
using generalized estimated equations (GEEs) on familial
dependence were performed to study associations between
plasma FlOPs levels and persistent asthma. To study only
the road traffic effect, estimates of associations between
road traffic with persistent asthma or plasma FlOPs levels
were also adjusted for background NO2. To obtain a better
temporality between outdoor air pollution assessed by
ESCAPE and plasma collection, analyses with back-
extrapolated pollution estimates were also performed.
We used a direct acyclic graph to represent our medi-
ation model (Fig. 1), and conducted mediation analysis
based on a counterfactual approach by using the CAUS
ALMED procedure [19, 20] (see Additional file 1). Medi-
ation analysis was performed for air pollutants associated
with both persistent asthma and plasma FlOPs levels, re-
gardless of the significance of the association between
air pollutant and persistent asthma. Models did not in-
clude random effects on center and familial dependence.
The four-way decomposition was used to investigate the
proportions of total effect that were attributable to the
controlled direct effect, to mediation (the pure indirect
effect), to interaction (the reference interaction between
pollutant and plasma FlOPs levels) and to both medi-
ation and interaction (the mediated interaction) [21].
Percentages mediated and due to interaction were given.
All these components were defined in Additional file 1.
All estimates were adjusted for age (continuous), sex
and smoking status (never-, ex- or current smokers). We
defined never-smoker as a participant who have never
smoked in their life, ex-smoker as a participant who quit
smoking for at least 4 weeks at EGEA2 and current
smoker as a participant who was smoking at least one
cigarette a day for more than 1 year at EGEA2. The re-
sults are expressed for an increase of 20 μg/m3 of NOx,
10 μg/m3 of NO2, PM10, O3 and O3-summer and 5 μg/m
3
of PM2.5. The results of traffic load are expressed for 4
million vehicles multiplied by meters per day on major
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roads within a 100 m buffer, and those of traffic intensity
for an increase of 5000 vehicles per day on major roads.
We performed sensitivity analyses by excluding partici-
pants who lived at the same address for < 1 year. Statis-
tical analyses were performed using SAS version 9.4
(SAS Institute, Cary, NC, USA).
Results
At EGEA2, the mean age of the 204 adults was 39 years,
48% were men, 24% were current smoker, 79% had per-
sistent asthma, and the geometric mean (interquartile
range) of plasma FlOPs levels was 92.0 (79.5–104.7)
RFU/mL (Table 1). In comparison to participants with
remittent asthma, participants with persistent asthma
had more often poor controlled asthma and an asthma
symptom score > 2, reported more often the use of in-
haled corticosteroids, and had higher plasma FlOPs
levels (all P values≤0.02, Table 1). Plasma FlOPs levels
increased with age (p-trend< 0.0001, Additional file 1:
Table S2), were lower in never smokers than smokers
(p = 0.02, Additional file 1: Table S2). No significant as-
sociation was found between plasma FlOPs levels and
other variables (Additional file 1: Table S2).
Associations between outdoor air pollution, plasma FlOPs
levels and persistent asthma
Among all pollutants studied, plasma FlOPs levels in-
creased by 1 RFU/mL with PM10 and O3 exposures (ad-
justed (a)β = 0.04, 95% CI 0.001–0.08, p = 0.03 and aβ =
0.04, 95% CI 0.009–0.07, p = 0.02 for an increase of
10 μg/m3 of O3 and PM10, respectively, Table 2). The re-
sults were similar after excluding participants who lived
at the same address for less than 1 year. The association
between PM10 and plasma FlOPs levels did not remain
significant with back-extrapolated data (aβ = 0.03, 95%
CI -0.01–0.07, p = 0.22 for an increase of 10 μg/m3 of
PM10, Table 2). The risk of persistent asthma decreased
not significantly with exposure to NO2, NOx and PM2.5
(aOR ranging from 0.62 to 0.94), and increased not
significantly with exposure to PM10, O3, O3-summer and road
traffic, the greater effect being observed for O3 (aOR= 1.78,
95% CI 0.73–4.37, for an increase of 10 μg/m3 of O3, model
2, Additional file 1: Table S3). Results were similar after ex-
cluding participants who lived at the same address for less
than 1 year (Table 2 and Additional file 1: Table S3). Further
adjustment for season of plasma collection did not change
the results with O3 (data not shown). The risk of persistent
asthma increased with plasma FlOPs levels (unadjusted
OR= 1.68, 95% CI 1.04–2.70, p= 0.03 for an increase of 1
interquartile range of FlOPs levels), and this association
remained consistent after adjustment for age, sex and smok-
ing status (aOR= 1.81, 95% CI 1.08–3.02, p = 0.02) for an
increase of 1 interquartile range of FlOPs levels).
Ozone, FlOPs levels and persistent asthma: mediation
analysis
Results were summarized in Table 3. We observed a posi-
tive total effect (ORTE = 2.16, 95% CI 0.70–11.9, P > 0.05),
a positive natural direct effect of O3 on persistent asthma
(ORCDE = 1.68, 95% CI 0.57–7.25, P > 0.05), and a positive
natural indirect effect mediated by plasma FlOPs levels
(ORNIE = 1.28, 95% CI 1.01–2.29, P = 0.04). Further de-
composition of total effect showed that 50.3% of total ef-
fect was due to control direct effect, 8.6% due to the
reference interaction, 26.5% due to mediated interaction
and 14.6% due to the pure indirect effect. The percentage
of total effect mediated by plasma FlOPs levels was 41.1%
(26.5% + 14.6%). The percentage of total effect due to
interaction was 35.1% (8.6% + 26.5%). These results were
quite similar after excluding participants who lived at the
same address for < 1 year (Additional file 1: Table S4). We
also found that the controlled direct effect increased with
plasma FlOPs levels (Additional file 1: Table S5).
Discussion
We studied and quantified the role of plasma FlOPs
levels in the association between outdoor air pollution
and persistent asthma. We found that plasma FlOPs
Fig. 1 Direct acyclic graph of the proposed mediation model. FlOPs: fluorescent oxidation products
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levels increased with PM10 and O3 exposures, and the
risk of persistent asthma increased with plasma FlOPs
levels. We also found that the risk of persistent asthma
increased with O3 exposure, but not significantly. We
therefore performed mediation analysis to investigate
the role of plasma FlOPs levels in the association
between O3 exposure and persistent asthma. We found
positive indirect effect mediated by plasma FIOPs levels
accounting for 41% of the total effect, and O3 effect on
persistent asthma increased with plasma FlOPs levels.
Due to the limited sample size and borderline significant
findings, and to the other biomarkers related to
Table 1 Description of participants with current asthma at baseline (EGEA2) according to change in current asthma between EGEA2
to EGEA3
All participants Participants with remittent asthma Participants with persistent asthma P-value
N 204 43 161
Age (years), mean ± SD 39.3 ± 16.9 36.7 ± 15.3 40.0 ± 17.3 0.26
Male, n (%) 99 (48.5) 16 (37.2) 83 (51.6) 0.09
Smoking status, n (%)
Never-smoker 109 (53.4) 22 (51.2) 87 (54.0) 0.52
Ex-smoker 46 (22.6) 8 (18.6) 38 (23.6)
Current smoker 49 (24.0) 13 (30.2) 36 (22.4)
BMI (kg/m2), mean ± SD n = 203 23.4 ± 3.99 n = 160 0.40
23.8 ± 3.84 23.9 ± 3.81
Socioprofessional category, n (%)
Unemployed 32 (15.7) 5 (11.6) 27 (16.8) 0.37
Manager 64 (31.4) 12 (27.9) 52 (32.3)
Technician 88 (43.1) 19 (44.2) 69 (42.8)
Manual worker 20 (9.8) 7 (16.3) 13 (8.1)
Asthma onset years, mean ± SD N = 195 N = 39 N = 156 0.40
14.8 ± 14.7 16.6 ± 14.6 14.4 ± 14.7
Poor controlled asthmaa, n (%) N = 190 N = 38 N = 152 0.007
102 (53.7) 13 (34.2) 89 (58.6)
Use of inhaled corticosteroids, n (%) N = 200 N = 41 N = 159 0.009
132 (66.0) 20 (48.8) 112 (70.4)
Symptom score of asthmab, n (%) N = 199 N = 40 N = 159
0 20 (10.0) 9 (22.5) 11 (6.9) 0.005
1–2 30 (15.1) 8 (20.0) 22 (13.8)
>2 149 (74.9) 23 (57.5) 126 (79.3)
Plasma FlOPs levels (RFU/mL), GM (q1-q3) 92.0 (79.5–104.7) 85.6 (76.0–96.5) 93.8 (79.9–104.8) 0.02
Residence time (years), mean ± SD 11.7 ± 10.2 (0–42) 10.3 ± 8.90 (0–31) 12.1 ± 10.5 (0–42) 0.31
Air pollutant levels and traffic metricsc, mean ± SD
NO2 27.9 ± 13.9 29.7 ± 15.3 27.4 ± 13.5 0.34
NOX 49.7 ± 32.7 53.2 ± 38.4 48.8 ± 31.0 0.44
PM10 25.0 ± 4.07 25.1 ± 3.71 24.9 ± 4.18 0.88
PM2.5 15.0 ± 2.04 15.5 ± 1.96 14.9 ± 2.05 0.20
Traffic load 1,755,353 ± 4,718,630 1,672,062 ± 4,007,561 1,777,599 ± 4,902,148 0.90
Traffic intensity 7307 ± 13,109 7027 ± 11,360 7382 ± 13,569 0.87
O3 43.9 ± 4.62 43.1 ± 4.08 44.2 ± 4.74 0.15
O3-summer 65.4 ± 6.20 64.7 ± 6.41 65.6 ± 6.14 0.38
SD standard deviation, BMI body mass index, FlOPs fluorescent oxidation products, GM geometric mean; q1-q3: 25th and 75th percentiles of the GM
aDefined according to GINA 2015 guidelines and from participants with partly controlled asthma or uncontrolled asthma (see Additional file 1)
bMore details in Additional file 1
cPollutant levels in μg/m3, traffic load in vehicles/day x meters, and traffic intensity in vehicles/day
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oxidative stress potentially involved in this association,
the results need to be interpreted with caution.
To our knowledge, this study is the first one investigat-
ing the associations between outdoor air pollution and
plasma FlOPs levels. FlOPs levels are biomarkers of dam-
ages related to oxidative stress reflecting a mixture of oxi-
dation products from lipids, proteins and DNA [6]. These
biomarkers are of growing interest in epidemiological
studies because they are stable, easily measurable and ap-
plicable in large-scale human studies [9]. We found that
plasma FlOPs levels increased with long-term exposure to
O3, an irritant gas with a strong oxidative potential [5]. To
date, no study has investigated the associations between
O3 exposure and plasma FlOPs levels, and a recent review
reported positive and significant associations between
short-term exposure to O3 and 8-isoprostane, another
biomarker related to oxidative stress [22]. We did not have
data to properly assess by which extent acute exposure to
O3 (over the past hours/days) could have biased our re-
sults. Nevertheless, the adjustment for the season of
plasma collection did no change the results. As plasma
FlOPs levels are biomarkers of damages that reflect cumu-
lative oxidative stress, we hypothesized to find associations
with long-term exposure to air pollution rather than with
short-term air pollution. Further studies are needed to dif-
ferentiate the effects of short-term and long-term expos-
ure to air pollution, and in particular O3, on plasma FlOPs
levels. We also found that plasma FlOPs levels increased
with non-back extrapolated PM10. The way and the
strength of the association with back-extrapolated PM10
were the same, but the association was not significant due
to the small effective. Previously, we found that 8-
Table 2 Associations between outdoor air pollution and plasma FlOPs levels
NO2 NOx PM10
a PM2.5
a Total traffic load on
major roads in a 100-m
buffer of the homeb
Traffic intensity at
the road nearest to a
participant’s homeb
O3 O3-sumer
Model
1
n
β crude
(95% CI)
P
204
0.007
(− 0.004,
0.02)
0.19
204
0.006
(− 0.003,
0.02)
0.15
146
0.04
(0.001,0.08)
0.04
146
0.03
(− 0.009,
0.07)
0.15
204
0.008
(− 0.005,0.02)
0.24
204
0.0004
(− 0.005,0.006)
0.88
204
0.03
(− 0.004,
0.06)
0.06
204
0.02
(− 0.03,
0.07)
0.36
Model
2
n
β
adjusted
(95% CI)
P
204
0.007
(− 0.003,
0.02)
0.18
204
0.007
(− 0.002,
0.02)
0.16
146
0.04
(0.001,0.08)
0.03
146
0.03
(− 0.008,
0.07)
0.18
204
0.006
(− 0.006,0.02)
0.30
204
0.0002
(− 0.005,0.006)
0.94
204
0.04
(0.009,0.07)
0.02
204
0.02
(− 0.02,
0.06)
0.45
Model
3
n
β
adjusted
(95% CI)
P
204
0.007
(− 0.002,
0.02)
0.14
204
0.006
(− 0.002,
0.01)
0.12
72
0.03
(− 0.01,
0.07)
0.22c
Model
4
n
β
adjusted
(95% CI)
P
186
0.009
(− 0.003,
0.02)
0.14
186
0.008
(− 0.002,
0.02)
0.14
133
0.05
(0.006,0.09)
0.04
133
0.02
(− 0.02,0.06)
0.24
186
0.003
(− 0.01,0.02)
0.63
186
0.0005
(− 0.005,0.006)
0.86
186
0.05
(0.01,0.08)
0.01
186
0.02
(− 0.03,
0.07)
0.37
The linear regression models were conducted with random effects on familial dependence and center. FlOPs levels were log10-transformed. NO2, nitrogen dioxide;
NOx, nitrogen oxides; PM10, particulate matter with a diameter ≤ 10 μm; PM2.5, particulate matter with a diameter ≤ 5 μm. Results are expressed per 20 μg/m
3
increase of NOx exposure, per 10 μg/m
3 increase of NO2, PM10 O3 and O3-summer exposures, per 5 μg/m
3 increase of PM2.5 exposure, per 4 million vehicles x meters
per day increase of total traffic load, per 5000 vehicles per day increase of traffic intensity. Model 1: unadjusted. Model 2: adjusted for age, sex and smoking
status. Model 3: with back-extrapolated pollution and adjusted for age, sex and smoking status. Model 4: after excluding the participants living at the same
residential address <1 year
aNot back-extrapolated PM were only estimated in Paris and in Grenoble, and back extrapolated PM10 only in Paris
bEstimates were also adjusted for background NO2
cThe linear regression model was only conducted with random effects on familial dependence because back-extrapolated PM10 were estimated only in Paris
Table 3 Results of mediation analysis between O3, persistent
asthma and plasma FlOPs levels using the CAUSALMED
procedure (n = 204)
OR Estimate 95% CI
Odds Ratio Total Effect 2.16 0.70–11.9
Odds Ratio Natural Direct Effect 1.68 0.57–7.25
Odds Ratio Natural Indirect Effect 1.28 1.01–2.29
Decomposition of the total effect
Four-way Percent
Controlled direct 50.3
Reference interaction 8.6
Mediated interaction 26.5
Pure indirect 14.6
Models were adjusted for age, sex and smoking habits. The exposure was O3.
The mediators were plasma FlOPs levels. The outcome was persistent asthma
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isoprostane in exhaled breath condensate, a matrix close
to the lungs, increased significantly with PM2.5 exposure
in the EGEA study [23]. 8-isoprostane is a biomarker of
damages related to oxidative stress, and a specific product
of lipid peroxidation. In the present analysis, plasma FlOPs
levels increased with PM2.5 exposure but the association
was not significant. Fine and ultrafine particulates are
known to be more harmful by penetrating deeper into the
lungs and inducing damages due to oxidative stress both
at the airways and systemic compartment [24]. The dis-
crepancies in the results could be partly explained by
difference in the sample sizes, in the composition and
concentration of the particulates, and by difference in
underlying mechanism related to the studied biomarker.
In a previous work conducted among participants without
asthma in the EGEA study, occupational exposure to irri-
tant cleaning/disinfecting agents increased plasma FlOPs
levels [13]. Overall, all these results underlined that occu-
pational exposure to irritants, and outdoor air pollution
exposure, especially exposure to O3 and PM10, were asso-
ciated with higher plasma FlOPs levels, and outdoor air
pollution increased oxidative stress at both lung and
systemic level.
We studied persistent asthma in association with O3,
PM and plasma FlOPs levels. Asthma is a chronic and
heterogeneous disease defined by various overlapping
phenotypes, including the phenotype “persistent asthma”
[25]. Although persistent asthma is still under-studied in
epidemiology, it reflects the activity and the evolution of
asthma over time. Most associations between pollution
and persistent asthma were close to 1; the risk of persist-
ent asthma decreased with PM2.5 and increased with O3
and O3-summer exposures. The unexpected result ob-
served for PM2.5 may be partly due to the lack of back-
extrapolated data leading to an inverse temporality
between PM2.5 and persistent asthma, or to random ef-
fect or residual bias. To date, only one study investigated
the associations between exposure to outdoor air pollu-
tion and with persistent asthma in adults, and showed
that living within 200 m of a major road was associated
with persistent asthma in middle-aged Tasmanian par-
ticipants [3]. Like us, the authors defined “current
asthma” as “any episode of asthma or use of asthma
medication during the last 12 months”. We also found
that the risk of persistent asthma increased with plasma
FlOPs levels. Our definition of “current asthma” in-
cluded the report of asthma attack and the use of
respiratory treatment in the last twelve months, and
interestingly in adults of the EGEA study, asthma at-
tacks, any asthma treatment and use of inhaled cortico-
steroids in the past 12 months were positively associated
with plasma FlOPs levels [11]. Interestingly, leukocyte
telomere length, which reflects oxidative-stress damages
to DNA [26], was shorter in participants who had
persistent asthma from childhood into adult as com-
pared to those who had adolescent or adult-onset
asthma [27]. From a larger sample size, it would be now
interesting to study the associations between outdoor air
pollution, plasma FlOPs levels and asthma incidence.
We acknowledge that performing a mediation analysis
despite the non-significant association between O3 and
persistent asthma may open a debate. We based our de-
cision on the biological hypothesis that oxidative stress
is one mechanism by which outdoor air pollution affects
respiratory health. Although the association between O3
and persistent asthma was non-significant, the strength
of the association between O3 and persistent asthma,
and previous results obtained in the EGEA study guided
our decision. Indeed, O3 was associated with severe
asthma [18], uncontrolled asthma [28] and current
asthma [23] in adults.
The CAUSALMED procedure is a recent tool available
in SAS software to estimate causal mediation effects
from observational data [19]. This procedure is advisable
without prior knowledge about the lack of the inter-
action [29]. In mediation analysis, the random effects on
center and familial dependence were not taken into in
models, explaining the differences of results between the
association between O3 and persistent asthma studied
outside the mediation analysis and the direct effect. Be-
yond direct and indirect effects, the four-way decompos-
ition shed insights into the role of both mediation and
interaction in the associations between O3 and plasma
FlOPs levels with persistent asthma. Overall, our medi-
ation analysis may suggest a not negligible effect of O3
on persistent asthma through plasma FlOPs levels, and
more precisely that effect of O3 on persistent asthma in-
creased with plasma FlOPs levels. Due to the small sam-
ple size, the estimates from mediation analysis may be
imprecise and the results should therefore be interpreted
with caution. Further studies, with a larger study sample,
using a model including other biomarkers related to oxi-
dative stress or biomarkers related to other pathways, as
well as the interrelations between these biomarkers,
would be helpful to better understand the underlying
biological mechanisms between outdoor air pollution
and asthma.
Conclusion
For the first time in adults, we found that plasma FlOPs
levels increased with O3 and PM10 exposures, and the
risk of persistent asthma increased with plasma FlOPs
levels. Overall, our results add insights into the potential
role of plasma FlOPs levels in the association between
O3 and persistent asthma, and add new evidence on the
role of oxidative stress in the association between out-
door air pollution and asthma.
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